These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27500873)

  • 1. [A randomized single blind study of the efficacy of pregabalin in the treatment of opioid withdrawal syndrome].
    Krupitsky EM; Ilyuk RD; Mikhailov AD; Kazankov KA; Rybakova KV; Skurat EP; Grishina OG; Zaplatkin IA; Vetrova MV; Neznanov NG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(7):29-36. PubMed ID: 27500873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lofexidine versus diazepam for the treatment of opioid withdrawal syndrome: A double-blind randomized clinical trial in Singapore.
    Guo S; Manning V; Yang Y; Koh PK; Chan E; de Souza NN; Assam PN; Sultana R; Wijesinghe R; Pangjaya J; Kandasami G; Cheok C; Lee KM; Wong KE
    J Subst Abuse Treat; 2018 Aug; 91():1-11. PubMed ID: 29910009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal.
    Gorodetzky CW; Walsh SL; Martin PR; Saxon AJ; Gullo KL; Biswas K
    Drug Alcohol Depend; 2017 Jul; 176():79-88. PubMed ID: 28527421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial.
    Martinotti G; di Nicola M; Frustaci A; Romanelli R; Tedeschi D; Guglielmo R; Guerriero L; Bruschi A; De Filippis R; Pozzi G; Di Giannantonio M; Bria P; Janiri L
    Addiction; 2010 Feb; 105(2):288-99. PubMed ID: 20078487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Lofexidine for Medically Managed Opioid Withdrawal: A Randomized Controlled Clinical Trial.
    Fishman M; Tirado C; Alam D; Gullo K; Clinch T; Gorodetzky CW;
    J Addict Med; 2019; 13(3):169-176. PubMed ID: 30531234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment.
    Rudolf G; Walsh J; Plawman A; Gianutsos P; Alto W; Mancl L; Rudolf V
    Am J Drug Alcohol Abuse; 2018; 44(3):302-309. PubMed ID: 28795846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Willis-Ekbom disease/restless legs syndrome in patients with opioid withdrawal.
    Gupta R; Ali R; Ray R
    Sleep Med; 2018 May; 45():39-43. PubMed ID: 29680426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varenicline for opioid withdrawal in patients with chronic pain: a randomized, single-blinded, placebo controlled pilot trial.
    Hooten WM; Warner DO
    Addict Behav; 2015 Mar; 42():69-72. PubMed ID: 25462656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of polydrug-using opiate dependents during withdrawal: towards a standardisation of treatment.
    Kristensen Ø; Lølandsmo T; Isaksen A; Vederhus JK; Clausen T
    BMC Psychiatry; 2006 Nov; 6():54. PubMed ID: 17107609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baclofen versus clonidine in the treatment of opiates withdrawal, side-effects aspect: a double-blind randomized controlled trial.
    Ahmadi-Abhari SA; Akhondzadeh S; Assadi SM; Shabestari OL; Farzanehgan ZM; Kamlipour A
    J Clin Pharm Ther; 2001 Feb; 26(1):67-71. PubMed ID: 11286609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of acetorphan with clonidine for opiate withdrawal symptoms.
    Hartmann F; Poirier MF; Bourdel MC; Loo H; Lecomte JM; Schwartz JC
    Am J Psychiatry; 1991 May; 148(5):627-9. PubMed ID: 2018165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial.
    Förg A; Hein J; Volkmar K; Winter M; Richter C; Heinz A; Müller CA
    Alcohol Alcohol; 2012; 47(2):149-55. PubMed ID: 22215002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of opiate withdrawal symptoms with use of clonidine in a county jail.
    Fresquez-Chavez KR; Fogger S
    J Correct Health Care; 2015 Jan; 21(1):27-34. PubMed ID: 25431436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity of opiate withdrawal in relation to the 825C>T polymorphism of the G-protein beta 3 subunit gene.
    Lieb B; Bonnet U; Specka M; Augener S; Bachmann HS; Siffert W; Scherbaum N
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):663-7. PubMed ID: 19303909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial.
    Akhondzadeh S; Kashani L; Mobaseri M; Hosseini SH; Nikzad S; Khani M
    J Clin Pharm Ther; 2001 Oct; 26(5):369-73. PubMed ID: 11679027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification.
    Glasper A; Gossop M; de Wet C; Reed L; Bearn J
    Pharmacology; 2008; 81(2):92-6. PubMed ID: 17952010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal.
    Akhondzadeh S; Ahmadi-Abhari SA; Assadi SM; Shabestari OL; Kashani AR; Farzanehgan ZM
    J Clin Pharm Ther; 2000 Oct; 25(5):347-53. PubMed ID: 11123486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts.
    Kosten TR; Rounsaville BJ; Kleber HD
    Am J Drug Alcohol Abuse; 1985; 11(1-2):1-10. PubMed ID: 3904410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study.
    Magnelli F; Biondi L; Calabria R; Fiore A; Peluso E; Vonella D; Rota AG
    Clin Drug Investig; 2010; 30 Suppl 1():21-6. PubMed ID: 20450242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.